BOARD
- President: Alba Vergés i Bosch, Consellera de Salut
- 1st Vicepresident: Maria Àngels Chacón i Feixas, Conseller d’Empresa i Coneixement
- 2nd Vicepresident: Joan Elias García, Rector UB
- Secretary: Montserrat Figuerola Batista, Gerent de l’Àrea Metropolitana Sud de l’ICS
- Chair: Joan Gómez Pallarès, Director General de Recerca
- Chair: Albert Barberà Lluís, Director General de Recerca del Departament de Salut
- Chair: Domènec Espriu Climent, Vicerector Recerca UB
- Chair: Candela Calle Rodríguez, Directora General ICO
- Chair: Cristina Capdevila Aguilera, Directora de Centre HUB
- Chair: Josep M. Vilà Cortasa, President de l’Institut Català d’Oncologia
- Chair: Núria Marin Martínez, Alcaldessa
- Chair: Francesc Xavier Grau i Vidal, Secretari d’Univesitats i Recerca
- Chair: Lluís Rovira i Pato, Director de la Institució dels Centres de Recerca de Catalunya (CERCA)
- Chair: Iolanda Font de Rubinat Garcia, Subdirectora General de Recerca
- Chair: Jaume Reventós Puigjaner, Coordinador d’Estratègia i Relacions Institucionals
- Chair: Josep Batista Trobalón, Vicerector Personal Docent i Investigador
SCIENTIFIC ADVISORY BOARD
- Ernest Arenas Cases, MD, PhD. Professor of Stem Cell Neurobiology & Chairman of the Department of Medical Biochemistry and Biophysics. Karolinska Institut, Sweden
- Paolo Gasparini, PhD. Istituto di Ricovero e Cura a Carettere Scientifico maternoinfantile Burlo Garofolo, Trieste
- Lisardo Boscà Gomar, PhD. Centro de Investigaciones Biomédicas Alberto Sols, Madrid
- Robert Sackstein, MD, PhD. Professor, Harvard Medical School Director, Program of Excellence in Glycosciences. Physician, Brigham & Women’s Hospital/Dana Farber Cancer Institute, Boston, MA, USA
- Ana Aranda Iriarte, PhD. Departamento de Fisiopatología Endocrina y del Sistema Nervioso, Instituto de investigaciones Biomédicas “Albert Sols”
- Sonia Martínez Arca, PhD. Directora Gerente Agencia de Conocimiento en Salud, ACIS
INTERNAL SCIENTIFIC COMITTEE
Program coordinators:
Cancer area:
1. Ramon Salazar (ICO/UB) – Molecular Mechanisms and Experimental Therapy in Oncology
2. Alex Vaquero (FIDIBELL) – Epigenetics and cancer biology
3. Xavier Bosch (ICO/UB) – Epidemiology, Public Health, Cancer Prevention and Palliative Care
Neuroscience area:
4. Francisco Ciruela (UB) – Neuroscience
Translational medicine area:
5. Eduard Montanya (HUB/UB) – Diabetes and metabolism
6. Virginia Nunes (FIDIBELL/UB) – Genes, disesase and therapy
7. Àngel Cequier (HUB/UB) – Cardiovascular, Respiratory and Systemic Diseases and cellular aging
8. Josep Manuel Llop (HUB/UB) – Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention
9. Jordi Carratalá (HUB/UB) – Infectious disease and transplantation
Regenerative medicine area:
10. Ángel Raya – Regenerative Medicine
Extended Executive board
11. Òscar Martínez Tirado (FIDIBELL) – Representative FIDIBELL
12. Josep Maria Cruzado (HUB/UB) – Representative HUB
Other members:
13. Francesc Xavier Matias- Guiu (HUB) – Scientific director Biobank
14. Cristina Muñoz (FIDIBELL) – Miguel Servet and/or Ramon y Cajal researcher
15. Eva González (FIDIBELL) – ERC researcher
16. Ruth de Diego (UB) – ICREA researcher
17. Miquel Angel Pujana (ICO) – Oncobell member
18. Maria Antonia Perelló (Viladecans/UB) – Viladecans researcher
19. Oriol Casanovas (ICO) – ERC researcher
20. Montserrat Martín – Scientific director, Consorci Sanitari Integral
Organizational chart
*In 2018, the CMR[B] began a transition process to become a new research area
within IDIBELL, process that became fully completed in the end of 2019.
General director
Gabriel Capellá
Scientific area
Josep Manuel Menchón
Strategy
Marina Rigau
Business development & Innovation
Raquel Egea
Management
Magda Martí
People
tba
